Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study
=============================================================================================================================================================

* Paolo Andrea Zucali
* Chia-Chi Lin
* Bradley C Carthon
* Todd M Bauer
* Marcello Tucci
* Antoine Italiano
* Roberto Iacovelli
* Wu-Chou Su
* Christophe Massard
* Mansoor Saleh
* Gennaro Daniele
* Alastair Greystoke
* Martin Gutierrez
* Shubham Pant
* Ying-Chun Shen
* Matteo Perrino
* Robin Meng
* Giovanni Abbadessa
* Helen Lee
* Yingwen Dong
* Marielle Chiron
* Rui Wang
* Laure Loumagne
* Lucie Lépine
* Johann de Bono